Action and Impact
Walking impairment can be one of the most challenging symptoms of multiple sclerosis (MS), but research showed the impact of mobility loss was not widely understood by both clinicians and patients.
We often work with private, developmental stage companies preparing to disrupt current standard of care with innovative new treatment options.
Engaging the Public
Historically it has often been a challenge to connect rare disease patients with each other and with available resources and information.
We have more than two decades of experience supporting clients through all stages of the regulatory approval process for drugs and medical devices.